Association Between Low Birth Weight and Dementia Risk: A Large-scale Prospective Study

YU Xinyue, XUE Qingping, LI Jingyi, ZHANG Peiqi, OUYANG Qingqing, LUO Xiaoxue, HE Qian, WANG Yongliu, ZHAO Ying,

Abstract

To investigate the association between birth weight and dementia risk and the mediating roles of chronic diseases, and to assess potential biological pathways underlying the birth weight-associated dementia risk based on large-scale proteomics.

Methods 

We used data from 279743 participants aged 40 to 69 years enrolled in the UK Biobank. Birth weight was categorized into low birth weight (≤ 2500 g), normal birth weight (2500-3999 g), and macrosomia (≥ 4000 g). Multivariable Cox proportional hazards regression models were used to assess the associations between birth weight categories and all-cause dementia and its subtypes (Alzheimer's disease and vascular dementia). Proteomics analyses were conducted to identify proteins and the potential pathways involved.

Results 

Low birth weight was associated with higher risks for all-cause dementia and its subtypes. The hazard ratios were 1.18 (95% CI, 1.08-1.30) for all-cause dementia, 1.14 (95% CI, 1.00-1.31) for Alzheimer's disease, and 1.22 (95% CI, 1.01-1.48) for vascular dementia. A non-linear relationship was observed between birth weight and dementia risk (P for nonlinearity < 0.001). Certain cardiometabolic diseases in middle-aged adults, such as diabetes, stroke, hypertension, and dyslipidemia, played a significant mediating role in the relationship between low birth weight and dementia risk, with the mediation proportion being 6.3% to 15.8%. Proteomic analyses identified 21 proteins linked to both low birth weight and all-cause dementia risk, which were significantly enriched in the pathways for viral protein interaction with cytokines and cytokine receptors, adipocytokine signaling, and cytokine-cytokine receptor interaction.

Conclusion 

Low birth weight is positively associated with dementia risk. Cardiometabolic diseases in middle-aged adults may mediate the relationship between low birth weight and dementia risk. A number of proteins and the associated pathways underscore the relationship between low birth weight and dementia risk.

 

Keywords: Birth weight, Dementia, Proteomics, Alzheimer's disease, Vascular dementia 

 

 

Full Text:

PDF


References


GBD 2019 Dementia Forecasting Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health, 2022, 7(2): e105-e125. doi: 10.1016/S2468-2667(21)00249-8.

WIEGERSMA AM, BOOTS A, LANGENDAM M W, et al. Do prenatal factors shape the risk for dementia? A systematic review of the epidemiological evidence for the prenatal origins of dementia. Soc Psychiatry Psychiatr Epidemiol, 2023. doi: 10.1007/s00127-023-02471-7.

McNEIL C J, HABOTA T, SANDU A L, et al. The influence of birth weight, socio-economic status, and adult health on brain volumes during ageing. Neuroepidemiology, 2024, 14: 1-9. doi: 10.1159/000541918.

MOSING M A, LUNDHOLM C, CNATTINGIUS S, et al. Associations between birth characteristics and age-related cognitive impairment and dementia: A registry-based cohort study. PLoS Med, 2018, 15(7): e1002609. doi: 10.1371/journal.pmed.

WHEATER E, SHENKIN S D, MUÑOZ MANIEGA S, et al. Birth weight is associated with brain tissue volumes seven decades later but not with MRI markers of brain ageing. Neuroimage Clin, 2021, 31: 102776. doi: 10. 1016/j.nicl.2021.102776.

GROVE B J, LIM S J, GALE C R, et al. Birth weight and cognitive ability in adulthood: A systematic review and meta-analysis. Intelligence, 2017, 61: 146-158. doi: 10.1016/j.intell.2017.02.001.

CORSI D J, DAVEY SMITH G, SUBRAMANIAN S V. Commentary: challenges to establishing the link between birthweight and cognitive development. Int J Epidemiol, 2013, 42(1): 172-175. doi: 10.1093/ije/dyt022.

SHENKIN S D, DEARY I J, BATTY G D. Commentary: Birthweight and childhood cognition: the use of twin studies. Int J Epidemiol, 2011, 40(4): 1019-1021. doi: 10.1093/ije/dyr100.

PICHET BINETTE A, GAITERI C, WENNSTRÖM M, et al. Proteomic changes in Alzheimer’s disease associated with progressive Aβ plaque and tau tangle pathologies. Nat Neurosci, 2024, 27(10): 1880-1891. doi: 10. 1038/s41593-024-01737-w.

SOLOMON A, MANGIALASCHE F, RICHARD E, et al. Advances in the prevention of Alzheimer's disease and dementia. J Intern Med, 2014, 275(3): 229-250. doi: 10.1111/joim.12178.

LANGEH U, SINGH S. Targeting S100B protein as a surrogate biomarker and its role in various neurological disorders. Curr Neuropharmacol, 2021, 19(2): 265-277. doi: 10.2174/1570159X18666200729100427.

SUDLOW C, GALLACHER J, ALLEN N, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med, 2015, 12(3): e1001779. doi: 10. 1371/journal.pmed.1001779.

COLLINS R. What makes UK Biobank special, Lancet, 2012, 379(9822): 1173-1174. doi: 10.1016/S0140-6736(12)60404-8.

FOSTER H M E, CELIS-MORALES C A, NICHOLl B I, et al. The efect of socioeconomic deprivation on the association between an extended measurement of unhealthy lifestyle factors and health outcomes: a prospective analysis of the UK Biobank cohort. Lancet Public Health, 2018, 3(12): e576-e585. doi: 10.1016/S2468-2667(18)30200-7.

CRAIG CL, MARSHALL AL, SJÖSTRÖM M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc, 2003, 35: 1381-1395. doi: 10.1249/01.MSS.0000078924.61453.FB.

SABIA S, FAYOSSE A, DUMURGIER J, et al. Association of sleep duration in middle and old age with incidence of dementia. Nat Commun, 2021, 12: 2289. doi: 10.1038/s41467-021-22354-2.

SUN B B, CHIOU J, TRAYLOR M. Plasma proteomic associations with genetics and health in the UK Biobank. Nature, 2023, 622(7982): 329-338. doi: 10.1038/s41586-023-06592-6.

SCHOENFELD D. Partial residuals for the proportional hazards regression model. Biometrika, 1982, 69(1): 239-241. doi: 10.1093/biomet/ 69.1.239.

Van der WEELE T J, DING P. Sensitivity analysis in observational research: introducing the E-value. Ann Intern Med, 2017, 167(4): 268-274. doi: 10.7326/M16-2607.

COLE S R, CHU H, GREENLAND S. Multiple-imputation for measurement-error correction. Int J Epidemiol, 2006, 35(4): 1074-1081. doi: 10.1093/ije/dyl097.

TEHRANIFAR P, LIAO Y, FLOM J D, et al. Validity of self-reported birth weight by adult women: sociodemographic influences and implications for life-course studies. Am J Epidemiol, 2009, 170(7): 910-917. doi: 10. 1093/aje/kwp205.

BENJAMINI Y, HOCHBERG Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B, 1995, 57(1): 289-300. doi: 10.1111/j.2517-6161.1995.tb02031.x.

EMANUEL O M, LEE M, LUTSEY P L, et al. Association of birth weight with incident dementia: The Atherosclerosis Risk in Communities (ARIC) Neurocognitive Study. Alzheimer's Dement, 2023, 19(s22): e079218. doi: 10.1002/alz.079218.

ARABZADEH H, DOOSTI-IRANI A, KAMKARI S, et al. The maternal factors associated with infant low birth weight: an umbrella review. BMC Pregnancy Childbirth, 2024, 24(1): 316. doi: 10.1186/s12884-024-06487-y.

LIVINGSTON G, HUNTLEY J, LIU K Y, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet, 2024, 404(10452): 572-628. doi: 10.1016/S0140-6736(24)01296-0.

ZANETTI D, TIKKANEN E, GUSTAFSSON S, et al. Birthweight, type 2 diabetes mellitus, and cardiovascular disease: addressing the barker hypothesis with mendelian randomization. Circ Genom Precis Med, 2018, 11(6): e002054. doi: 10.1161/CIRCGEN.117.002054.

BACKHOUSE E V, SHENKIN S D, MCINTOSH A M, et al. Early life predictors of late life cerebral small vessel disease in four prospective cohort studies. Brain, 2021, 144(12): 3769-3778. doi: 10.1093/brain/awab331.

SCHAAPSMEERDERS P, VAN UDEN IW, TULADHAR A M, et al. Ipsilateral hippocampal atrophy is associated with long-term memory dysfunction after ischemic stroke in young adults. Hum Brain Mapp, 2015, 36(7): 2432-2442. doi: 10.1002/hbm.22782.

LU J J, XING X X, QU J, et al. Alterations of contralesional hippocampal subfield volumes and relations to cognitive functions in patients with unilateral stroke. Brain Behav, 2024, 14(8): e3645. doi: 10.1002/brb3.3645.

SIMATS A, LIESZ A. Systemic inflammation after stroke: implications for post-stroke comorbidities. EMBO Mol Med, 2022, 14(9): e16269. doi: 10. 15252/emmm.202216269.

KIM C, SOHN J H, JANG M U, et al. Association between Visit-to-Visit Glucose Variability and Cognitive Function in Aged Type 2 Diabetic Patients: A Cross-Sectional Study. PLoS One, 2015, 10(7): e0132118. doi: 10.1371/journal.pone.0132118.

ZHANG S, WANG A, LIU S, et al. Glycemic variability correlates with medial temporal lobe atrophy and decreased cognitive performance in patients with memory deficits. Front Aging Neurosci, 2023, 15: 1156908. doi: 10.3389/fnagi.2023.1156908.

ISIK F I, THOMSON S, CUETO J F, et al. A systematic review of the neuroprotective role and biomarker potential of GDF15 in neurodegeneration. Front Immunol, 2024, 15: 1514518. doi: 10.3389/fimmu.2024.1514518.

WEBBER K, PATEL S, KIZER J R, et al. Associations of serum GDF-15 levels with physical performance, mobility disability, cognition, cardiovascular disease, and mortality in older adults. medRxiv [Preprint], 2024 Aug 8:2024.08.07.24311629. doi: 10.1101/2024.08.07.24311629.

HUANG Q, TRUMPFF C, MONZEL A S, et al. Psychobiological regulation of plasma and saliva GDF15 dynamics in health and mitochondrial diseases. bioRxiv[Preprint], 2024. doi:10.1101/2024.04.19. 590241.

WANG D, DAY E A, TOWNSEND L K, et al. GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease. Nat Rev Endocrinol, 2021, 17(10): 592-607. doi: 10.1038/s41574-021-00529-7.

WANG D, TOWNSEND L K, DESORMEAUX G J, et al. GDF15 promotes weight loss by enhancing energy expenditure in muscle. Nature, 2023, 619(7968): 143-150. doi: 10.1038/s41586-023-06249-4.

PENCE B D. Growth differentiation factor-15 in immunity and aging. Front Aging, 2022, 3: 837575. doi: 10.3389/fragi.2022.837575.


Refbacks

  • There are currently no refbacks.